Daily Archives: March 30, 2020
Mon March 30 – 10 Stories of The Day!
30 Mar, 2020 | 02:30h | UTC
2 – Management of Critically Ill Adults With COVID-19 – JAMA
Editorial: Toward Universal Deployable Guidelines for the Care of Patients With COVID-19
Original Guideline: Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) – Intensive Care Medicine AND Infographics: The Surviving Sepsis Campaign Rapid Guidelines on the Management of Critically Ill Adults with COVID-19
Related Summary: Surviving Sepsis Campaign: COVID-19 Recommendations – CanadiEm
Related Guideline: COVID-19 rapid guideline: critical care – National Institute for Health and Care Excellence
3 – Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma – JAMA
Editorial: Convalescent Plasma to Treat COVID-19: Possibilities and Challenges
Commentaries: A new report raises hope that the blood of recovered patients can help treat severe coronavirus cases – Business Insider AND Plasma transfusion shows promise for COVID-19 treatment, says China study – UPI
See also: Investigational COVID-19 Convalescent Plasma – Emergency INDs – U.S. Food & Drug Administration
4 – COVID-19: Controversies on the Use of Face Masks
- Would everyone wearing face masks help us slow the pandemic? – Science
- Not wearing masks to protect against coronavirus is a ‘big mistake,’ top Chinese scientist says – Science
- More Americans Should Probably Wear Masks for Protection – The New York Times
- Experts say face masks can help slow COVID-19, despite previous claims – New York Post
- Coronavirus: Chinese scientist advises people in Europe, US to wear face masks in public – South China Morning Post
Related Guidance: WHO Recommendations on when and how to use masks – World Health Organization AND Strategies for Optimizing the Supply of Facemasks – Centers for Disease Control and Prevention
5 – N95 Re-Use Instructions – SAGES
Related: Conserving Supply of Personal Protective Equipment—A Call for Ideas – JAMA AND N95 mask can be decontaminated without decreasing filtration efficiency – Stanford Medicine
Related Guidelines: HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19 – American College of Cardiology AND The Renal Association, UK position statement on COVID-19 and ACE Inhibitor/Angiotensin Receptor Blocker use AND Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers – European Society of Cardiology
7 – A War on Two Fronts: Cancer Care in the Time of COVID-19 – Annals of Internal Medicine
Related Guidelines: COVID-19 rapid guideline: delivery of systemic anticancer treatments – National Institute for Health and Care Excellence AND Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal – Journal of the National Comprehensive Cancer Network
8 – Primary care & Coronavirus (COVID 19): key guidance, information and support – Medium
Related: Coronavirus disease 2019 (covid-19): a guide for UK GPs – The BMJ AND Covid-19: a remote assessment in primary care
9 – Potential Effects of Coronaviruses on the Cardiovascular System: A Review – JAMA Cardiology
Editorial: Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality
Related Articles: Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China – JAMA Cardiology AND Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) – JAMA Cardiology
Commentary: A Heart Attack? No, It Was the Coronavirus – The New York Times
10 – Coronavirus Disease (COVID-19) Updates / 30 March 2020 Edition
30 March 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)
JAMA Guideline Synopsis: Management of Critically Ill Adults With COVID-19
30 Mar, 2020 | 02:17h | UTCManagement of Critically Ill Adults With COVID-19 – JAMA
Editorial: Toward Universal Deployable Guidelines for the Care of Patients With COVID-19
Original Guideline: Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) – Intensive Care Medicine
Related Summary: Surviving Sepsis Campaign: COVID-19 Recommendations – CanadiEm
Related Guideline: COVID-19 rapid guideline: critical care – National Institute for Health and Care Excellence
NICE Guideline: Venous Thromboembolic Diseases
30 Mar, 2020 | 02:27h | UTC
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
30 Mar, 2020 | 02:12h | UTCTreatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma – JAMA
Editorial: Convalescent Plasma to Treat COVID-19: Possibilities and Challenges
Commentaries: A new report raises hope that the blood of recovered patients can help treat severe coronavirus cases – Business Insider AND Plasma transfusion shows promise for COVID-19 treatment, says China study – UPI
See also: Investigational COVID-19 Convalescent Plasma – Emergency INDs – U.S. Food & Drug Administration
N95 Re-Use Instructions
30 Mar, 2020 | 02:06h | UTCN95 Re-Use Instructions – SAGES
Related: Conserving Supply of Personal Protective Equipment—A Call for Ideas – JAMA AND N95 mask can be decontaminated without decreasing filtration efficiency – Stanford Medicine
COVID-19: Controversies on the Use of Face Masks
30 Mar, 2020 | 02:10h | UTC- Would everyone wearing face masks help us slow the pandemic? – Science
- Not wearing masks to protect against coronavirus is a ‘big mistake,’ top Chinese scientist says – Science
- More Americans Should Probably Wear Masks for Protection – The New York Times
- Experts say face masks can help slow COVID-19, despite previous claims – New York Post
- Coronavirus: Chinese scientist advises people in Europe, US to wear face masks in public – South China Morning Post
Related Guidance: WHO Recommendations on when and how to use masks – World Health Organization AND Strategies for Optimizing the Supply of Facemasks – Centers for Disease Control and Prevention
Primary Care & Coronavirus (COVID 19): Key Guidance, Information and Support
30 Mar, 2020 | 01:45h | UTCPrimary care & Coronavirus (COVID 19): key guidance, information and support – Medium
Related: Coronavirus disease 2019 (covid-19): a guide for UK GPs – The BMJ AND Covid-19: a remote assessment in primary care – The BMJ
Related Commentary on Twitter
I've written a blog for primary care on #coronavirus:
?️ Preparing, comms, diagnosis
? Remote consulting
? PPE
? Coding/meds
???? Pt resources
? Clinical advice for diff groups/ways of working
? General resources
?️ Professional support— Dipesh Gopal (@DipeshGopal) March 28, 2020
A War on Two Fronts: Cancer Care in the Time of COVID-19
30 Mar, 2020 | 01:51h | UTCA War on Two Fronts: Cancer Care in the Time of COVID-19 – Annals of Internal Medicine
Related Guidelines: COVID-19 rapid guideline: delivery of systemic anticancer treatments – National Institute for Health and Care Excellence AND Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal – Journal of the National Comprehensive Cancer Network
Video: Coronavirus (COVID-19) Update: Fairly Rationing ICU Care
30 Mar, 2020 | 01:30h | UTCCoronavirus (COVID-19) Update: Fairly Rationing ICU Care – JAMA
COVID-19 and Renin-Angiotensin System Blockers
30 Mar, 2020 | 02:00h | UTCRenin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers – Hypertension AND Commentary: COVID-19 alert: Heart and kidney patients should keep taking their medicines – University of Miami Miller School of Medicine
Related Guidelines: HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19 – American College of Cardiology AND The Renal Association, UK position statement on COVID-19 and ACE Inhibitor/Angiotensin Receptor Blocker use AND Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers – European Society of Cardiology
The Importance of Addressing Advance Care Planning and Decisions About Do-Not-Resuscitate Orders During Novel Coronavirus 2019 (COVID-19)
30 Mar, 2020 | 01:33h | UTC
Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington
30 Mar, 2020 | 01:27h | UTCSee also: Defining the Epidemiology of Covid-19 — Studies Needed – New England Journal of Medicine
Related Guidelines: Infection Prevention and Control guidance for Long-Term Care Facilities in the context of COVID-19 – World Health Organization (PDF) AND Preparing for COVID-19: Long-term Care Facilities, Nursing Homes – Centers for Disease Control and Prevention
Related Review: Coronavirus Disease 2019 in Geriatrics and Long‐term Care: The ABCDs of COVID‐19 – Journal of the American Geriatrics Society
Related Article: COVID-19 in a Long-Term Care Facility — King County, Washington, February 27–March 9, 2020 – CDC Morbidity and Mortality Weekly Report (free)
Review: Potential Effects of Coronaviruses on the Cardiovascular System
30 Mar, 2020 | 01:41h | UTCPotential Effects of Coronaviruses on the Cardiovascular System: A Review – JAMA Cardiology
Editorial: Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality
Related Articles: Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China – JAMA Cardiology AND Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) – JAMA Cardiology
Commentary: A Heart Attack? No, It Was the Coronavirus – The New York Times
#ACC20 – [Abstract only] Randomized Trial: Rivaroxaban or Enoxaparin in Nonmajor Orthopedic Surgery
30 Mar, 2020 | 01:20h | UTCRivaroxaban or Enoxaparin in Nonmajor Orthopedic Surgery – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: PRONOMOS: Rivaroxaban Better Than Enoxaparin in Preventing VTE After Nonmajor Orthopedic Surgery – American College of Cardiology (free) AND PROphylaxis in NON-Major Orthopedic Surgery – PRONOMOS – American College of Cardiology (free)
Just Presented at the 2020 American College of Cardiology Virtual Meeting (free access)
Study: Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility
30 Mar, 2020 | 01:22h | UTCCommentary: The Role of Asymptomatic and Presymptomatic in Spread of COVID-19 – Penn State Food Safety AND For Nursing Homes, Symptoms Aren’t Enough to Tell Who’s Sick – Associated Press
#ACC20 – [Abstract Only] Randomized Trial: Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation
30 Mar, 2020 | 01:13h | UTCAnticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: Antithrombotic Therapy After Transcatheter Aortic Valve Implantation in Patients With a Long-Term Indication for Oral Anticoagulation – POPular TAVI – American College of Cardiology (free)AND A-fib Patients Undergoing TAVR Do Better With OAC Alone: POPular TAVI – TCTMD (free)
Just Presented at the 2020 American College of Cardiology Virtual Meeting (free access)
#ACC20 – [Abstract Only] Randomized Trial: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
30 Mar, 2020 | 01:18h | UTCVericiguat in Patients with Heart Failure and Reduced Ejection Fraction – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA – TCTMD (free) AND VICTORIA: Vericiguat Associated With Reduced CV Death, HF Hospitalization in High-Risk HF Patients – American College of Cardiology
Just Presented at the 2020 American College of Cardiology Virtual Meeting (free access)
#ACC20 – [Abstract Only] Randomized Trial: Rivaroxaban in Peripheral Artery Disease after Revascularization
30 Mar, 2020 | 01:05h | UTCRivaroxaban in Peripheral Artery Disease after Revascularization – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: VOYAGER-PAD: Rivaroxaban Associated With Reduced Adverse Limb, CV Events in PAD Patients – American College of Cardiology (free) AND VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events – TCTMD (free)
Just Presented at the 2020 American College of Cardiology Virtual Meeting (free access)
#ACC20 – Randomized Trial: Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
30 Mar, 2020 | 01:03h | UTCSee also: Visual Abstract
Just Presented at the 2020 American College of Cardiology Virtual Meeting (free access)
#ACC20 – [Abstract Only] Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
30 Mar, 2020 | 01:12h | UTCApixaban for the Treatment of Venous Thromboembolism Associated with Cancer – New England Journal of Medicine (abstract Only – $ for full-text)
Commentaries: Caravaggio Trial: Apixaban Noninferior to Dalteparin in Treatment of Cancer-Associated VTE – American College of Cardiology (free) AND Apixaban, Dalteprin Shown to Have Same Bleeding Risk in Patients With Cancer – AJMC (free)
Just Presented at the 2020 American College of Cardiology Virtual Meeting (free access)